ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,92
0,00%
S&P 500
5.308,13
0,00%
US Dollar vs BRL
5,0975
-0,14%
Bitcoin
71.171,49
-0,37%
Brent Oil
82,585
-1,13%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Bright Minds Biosciences Inc (DRUG)

  7. Bright Minds Biosciences Inc (DRUG) Notícias

DRUG

Bright Minds Biosciences (DRUG)

Bright Minds Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:DRUG
DataHoraFonteTítuloCódigoCompanhia
26/02/202422:18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:DRUGBright Minds Biosciences Inc
12/02/202423:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:DRUGBright Minds Biosciences Inc
18/01/202414:57Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:DRUGBright Minds Biosciences Inc
29/12/202318:30Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:DRUGBright Minds Biosciences Inc
06/12/202319:08PR Newswire (Canada)Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by ManagementNASDAQ:DRUGBright Minds Biosciences Inc
08/08/202307:50GlobeNewswire Inc.Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101NASDAQ:DRUGBright Minds Biosciences Inc
20/07/202307:50GlobeNewswire Inc.Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101NASDAQ:DRUGBright Minds Biosciences Inc
11/07/202307:50GlobeNewswire Inc.Bright Minds Announces Effective Date of Share ConsolidationNASDAQ:DRUGBright Minds Biosciences Inc
22/06/202316:37Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:DRUGBright Minds Biosciences Inc
22/06/202307:50GlobeNewswire Inc.Bright Minds Announces Proposed Share ConsolidationNASDAQ:DRUGBright Minds Biosciences Inc
19/04/202307:50GlobeNewswire Inc.Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202NASDAQ:DRUGBright Minds Biosciences Inc
10/04/202307:50GlobeNewswire Inc.Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin ResearchNASDAQ:DRUGBright Minds Biosciences Inc
27/02/202308:50GlobeNewswire Inc.Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023NASDAQ:DRUGBright Minds Biosciences Inc
17/02/202308:50GlobeNewswire Inc.Bright Minds Biosciences Announces Non-Executive Director AppointmentNASDAQ:DRUGBright Minds Biosciences Inc
08/02/202318:05GlobeNewswire Inc.Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee RequirementsNASDAQ:DRUGBright Minds Biosciences Inc
27/01/202318:05GlobeNewswire Inc.Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyNASDAQ:DRUGBright Minds Biosciences Inc
09/01/202318:05GlobeNewswire Inc.Bright Minds Biosciences Announces Resignation of Board MemberNASDAQ:DRUGBright Minds Biosciences Inc
02/12/202221:06GlobeNewswire Inc.Bright Minds Biosciences Announces Closing of Non-Brokered Private PlacementNASDAQ:DRUGBright Minds Biosciences Inc
28/11/202208:50GlobeNewswire Inc.Bright Minds Biosciences Announces Non-Brokered Private PlacementNASDAQ:DRUGBright Minds Biosciences Inc
23/11/202213:35GlobeNewswire Inc.Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D., Ph.D. as Chief Medical OfficerNASDAQ:DRUGBright Minds Biosciences Inc
14/09/202218:29Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DRUGBright Minds Biosciences Inc
07/09/202207:50GlobeNewswire Inc.Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of DirectorsNASDAQ:DRUGBright Minds Biosciences Inc
31/08/202207:50GlobeNewswire Inc.Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet SyndromeNASDAQ:DRUGBright Minds Biosciences Inc
30/08/202216:35GlobeNewswire Inc.Bright Minds Biosciences Announces Closing of $4 Million Unit OfferingNASDAQ:DRUGBright Minds Biosciences Inc
23/08/202222:06GlobeNewswire Inc.Bright Minds Announces Pricing of Overnight Marketed Offering of UnitsNASDAQ:DRUGBright Minds Biosciences Inc
18/08/202216:33GlobeNewswire Inc.Bright Minds Biosciences Comments on Recent Trading ActivityNASDAQ:DRUGBright Minds Biosciences Inc
27/06/202207:50GlobeNewswire Inc.Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development OrganizationNASDAQ:DRUGBright Minds Biosciences Inc
12/05/202207:50GlobeNewswire Inc.Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet SyndromeNASDAQ:DRUGBright Minds Biosciences Inc
02/05/202207:50GlobeNewswire Inc.Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health SpecialtiesNASDAQ:DRUGBright Minds Biosciences Inc
19/04/202207:50GlobeNewswire Inc.Bright Minds Biosciences to Host Symposium on Therapeutic Developments within Dravet Syndrome and Featuring a Panel with Key Opinion LeadersNASDAQ:DRUGBright Minds Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:DRUG

Seu Histórico Recente

UNSW
CHIETH
Chi Gastoken by 1inch
LATK
SNEBTC
StrongNodeEdge Token
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados